Correction to: iHIVARNA phase IIa, a randomized, placebo-controlled, doubleblinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy – Butlletí de la Recerca

Correction to: iHIVARNA phase IIa, a randomized, placebo-controlled, doubleblinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy

by biblioteca on 20 de gener de 2020 with No hi ha comentaris

De Jong, W., Aerts, J., Allard, S., Brander, C., Buyze, J., Florence, E., … Gruters, R. (2019). Correction to: iHIVARNA phase IIa, a randomized, placebo-controlled, doubleblinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy (Trials DOI: 10.1186/s13063. Trials, 20(1). https://doi.org/10.1186/s13063-019-3940-0

Deixa un comentari Cancel·la les respostes